UK Government report shows improving vaccine confidence among ethnic minority groups

Minister for Equalities Kemi Badenoch MP and COVID hero GP, Dr Farzana Hussain, have issued a joint call for everyone to take the vaccine when they are offered it.

  • As Government publishes third report on COVID-19 disparities, the Minister for Equalities and hero GP, Dr Farzana Hussain, issue a joint call for everyone to take the vaccine when they are offered it.
  • Evidence shows vaccine confidence has steadily increased among ethnic minorities.
  • This follows flexible vaccine delivery, and targeted communications from government and medical professionals, and partnerships with broadcasters.

The call comes as data shows vaccine confidence has steadily increased following government action, with 93% of adults reporting positive sentiment towards the vaccine. However, some groups are still less likely to get the jab. 30% of Black or Black British adults reported vaccine hesitancy, the highest compared with all ethnic groups.

The Joint Committee on Vaccination and Immunisation has prioritised people based on age, with older people being offered the vaccination first. As the UK’s White population makes up a greater number of those in the older age categories, the percentage of those who have already received vaccinations is higher when compared with ethnic minority groups.

As the vaccine is rolled out to younger age groups the Government will continue its targeted action to ensure that ethnic minority people are willing to take the jab.

Minister for Equalities, Kemi Badenoch, said: “We are taking the vital action necessary to protect our families, communities and the country from the scourge of COVID-19. Our positive progress deploying the vaccine and promoting confidence in it has been a tireless, collective effort, from faith leaders, voluntary groups and the NHS all working together in every community to turn back the tide of COVID-19.

“We are not complacent and we will continue to tackle dangerous disinformation and work with trusted partners to promote confidence in the vaccine so everyone takes up their jab when they are offered it.

“Vaccines are the key to unlocking a return to normal life, and this Government will continue to do everything it can to ensure everyone is confident to take them.”

‘Hero’ GP, Dr Farzana Hussain, whose tireless efforts during the pandemic – including online campaigning and debunking of misinformation, and personally calling scores of patients who have yet to take the jab – have been key to fighting the virus, said: “It is really important that everyone takes the vaccine – unless all of us are protected, none of us are protected.

“The vaccines are very safe – they have been trialled on hundreds of thousands of volunteers by world-leading scientists, and now millions of doses have been given, just in the UK alone. I urge everyone to take the jab when they are offered it.”

Alongside this the Minister for Equalities will today publish the third quarterly report to the Prime Minister and Health and Social Care Secretary on progress to understand and tackle COVID-19 disparities experienced by individuals from ethnic minority groups.

The report sets out the swift and flexible action Government has taken to protect people, adapting the vaccine programme as it has rolled out to ensure everyone feels safe and able to get the vaccine, without being stigmatised.

Dr Masood Ahmed, Chief Medical Officer for the Black Country and West Birmingham CCG said: “We have strong, resilient communities and have been able to address vaccine hesitancy by connecting with people, listening to fears, and having meaningful conversations in order to reduce barriers, which is key for longer term sustainable solutions to address wider health inequalities.

“It’s so important that we share learnings to understand and address the health inequalities that COVID-19 has highlighted, and whilst we have had some success in reaching people and communities, there is still opportunity to do more.”

Dr Rohini Mathur, Assistant Professor of Epidemiology, London School of Hygiene & Tropical Medicine, said: “This report highlights the positive impact of increasing vaccine confidence in minority ethnic groups across England and points towards the importance of understanding the complex interaction between socio-economic, geographic, and health related factors in explaining disparities exacerbated by the COVID-19 pandemic.”

The report sets out the following next steps:

  • The Minister for Equalities to share the findings of her third quarterly report with the Joint Committee on Vaccination and Immunisation.
  • Department of Health and Social Care (DHSC) to consider how to apply the findings of the review of experiences of frontline healthcare workers and the UK-REACH study.
  • NHS England’s published data on vaccination uptake by ethnicity should be further disaggregated to provide percentage uptake by vaccine priority group cohorts and sex. This should include levels of unknown ethnicity and an assessment of how this might affect the interpretation of vaccination uptake for different ethnic groups.
  • NHS England and Improvement (NHSEI) should publish data about the use of the NHS COVID-19 app by different ethnic groups. This will inform activity to increase the uptake and continued use of the app.
  • DHSC and NHS should further investigate practical barriers to vaccine uptake by ethnicity to assess and address any intention-action gap.
  • DHSC should ensure that NHS organisations and GPs are provided with clear guidance and protocols about how ethnicity should be requested and recorded in health records.
  • RDU should engage with the Office for Statistics Regulation about priorities for improving the quality (including harmonisation, robustness and reliability) of ethnicity data on health records, drawing on others’ expertise as appropriate, and report back in the final quarterly report.
  • The Minister for Equalities and the Minister for COVID-19 Vaccine Deployment will continue a programme of engagement in the next 3 months, focusing on promoting vaccine uptake and encouraging asymptomatic testing, particularly for those within higher risk occupations, as sectors reopen.
  • As the COVID-19 vaccine rollout continues, the government’s Vaccine Confidence campaign will aim to inform, educate and empower those aged 18 to 50 to take up their vaccine. Using the tagline ‘Every Vaccination Gives Us Hope’ content will take an optimistic tone, aiming to reach and persuade younger audiences, including ethnic minority groups.
  • At each step of the government’s roadmap out of lockdown, tailored guidance and communications will continue to be shared through community and media channels to maximise reach and impact.

Communications

  • To drive forward uptake of the vaccine, the government has prioritised communications with ethnic minority people across the UK, that includes:
  • A partnership with 12 community radio stations, which has delivered key messages about vaccines in 13 different languages to 1.5 million people.
  • Television partnerships with 21 multicultural TV networks, delivering 30 second adverts on 43 TV stations in 9 languages, reaching approximately 3 million people each week.
  • A Department for Digital, Culture, Media and Sport social media campaign to tackle false vaccine information, which has been shared with more than 4 million people through community and local networks, reaching people from minority ethnic backgrounds.
  • Ethnic minority medical professionals promoting facts and dispelling myths about the vaccines online, including a series of videos with Dr Amir Khan, a GP from Yorkshire, whose video on the vaccine being halal reached more than 330,000 people.
  • A programme of Ministerial engagement, including a roundtable with Black African and Black Caribbean Faith Leaders and GPs, recognising the important role that churches play in promoting vaccine uptake amongst their congregations.
  • Celebrities and influencers, including Great British Bake Off star Nadiya Hussain, backing the NHS COVID-19 vaccine drive.
  • A short film backed by the NHS based on an open letter signed by Sir Lenny Henry and a range of high-profile celebrities encouraging Black adults in the UK to make informed decisions about the vaccine.

Sixty million and rising!

one of the greatest achievements in Health Service history’

Over 60 million doses of the coronavirus (COVID-19) vaccine have been administered, with 37.9 million people across the UK receiving at least one jab.

  • More than 22.6 million people in the UK have been vaccinated with both doses for the strongest possible protection
  • Public urged to get vaccine when eligible

Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the latest figures published yesterday (Sunday 23 May) show.

Health services across the UK have now administered a total of around 60.6 million vaccines since 8 December, including around 37.9 million people with their first dose (72%) and 22.6 million with both doses (43%), ensuring they have the strongest possible protection against COVID-19 from a second dose.

This comes as new real-world data shows the vaccines are reducing hospitalisations and deaths, saving more than 13,000 lives and preventing 39,100 hospitalisations in England by 9 May.

The government met its target of offering a vaccine to the most vulnerable by 15 April and remains on track to offer a first dose to all adults by the end of July. NHS England are sending texts inviting people to book a vaccination to those aged 32 and 33.

Health and Social Care Secretary, Matt Hancock said: “Shortly after vaccinating over 70% of adults in the UK with a first dose, we have hit yet another incredible milestone with over 60 million doses delivered in total.

“Our trailblazing vaccination programme – the biggest and most successful in NHS history – is another great British success story and a testament to what can be achieved when all 4 corners of country comes together to defeat this virus.

“Our country has one of the highest uptake rates in the world and I’m delighted that so many have answered our call to arms. If you have not yet come forward, and you are eligible, I urge you to take up the offer – it could save your life and protect your loved ones.”

To ensure people have the strongest possible protection against COVID-19, appointments for second doses have been brought forward from 12 to 8 weeks for the remaining people in the top 9 priority groups who have yet to receive both doses.

The move follows updated advice from the independent experts at the Joint Committee on Vaccination and Immunisation (JCVI), which has considered the latest available evidence and has recommended reducing the dosing interval to counter the threat of new variants of concern.

The UK government announced new ‘decisive actions’ to halt the spread of the B1.617.2 variant of concern first identified in India last week. Targeted activity is taking place to continue to drive vaccine uptake amongst eligible cohorts to protect the most vulnerable.

The government continues to work in close partnership with local authorities to ensure the right action is taken at the right time, and to boost uptake of the approved vaccines for those eligible in these areas.

The UK Government says they are also providing support to the Scottish government, who are adopting similar action to control the spread of variants in Glasgow and Moray.

The government and its scientific experts are monitoring the evolving situation and rates of variants closely, and will not hesitate to take additional action as necessary.

Vaccines Minister, Nadhim Zahawi said: “Today we hit yet another phenomenal achievement, with 60 million jabs in arms and over 4 in 10 people fully vaccinated with two doses.

“I want to pay tribute to the heroic work of NHS workers, volunteers, local authorities and civil servants across the whole country who have worked tirelessly to help make this happen.

“The vaccine is saving thousands of lives and provides invaluable protection from this virus, so when you get the offer please come forward for the jab.”

NHS England chief executive Sir Simon Stevens said: “This latest milestone in our ongoing fight against COVID-19 is another opportunity to thank everyone again working throughout this weekend to deliver the NHS COVID-19 vaccination programme come rain or shine, through thick and thin – undoubtedly one of the greatest achievements in Health Service history.

UK Government Minister for Scotland Iain Stewart said: “It’s superb to hear more great news about the vaccine rollout. This milestone underscores the incredible progress we are making right across the country in our fight against COVID-19.

“The UK government is supplying vaccines for people in all parts of the United Kingdom, and our fantastic NHS is working tirelessly to administer first and second doses.

“I’d encourage everyone to please take up the invitation to get the jab when it comes to help us all through this pandemic.”

The vaccine offers high levels of protection against symptomatic disease and even higher levels of protection against severe illness, hospitalisation and death from COVID-19.

Protection increases with the second dose which is why it’s vital that everyone gets both doses of the vaccine as soon as they are offered to them. Getting the vaccine makes people less likely to get infected and growing evidence shows that it also helps to prevent them from passing the virus on to others.

The latest data from Public Health England’s (PHE’s) real-world study shows the vaccines are already having a significant impact in the UK, reducing hospitalisations and deaths, saving at least 13,000 lives and preventing at least 39,100 hospitalisations in England by the 9 May. For the over 80s, it is estimated that 2 doses of the Pfizer-BioNTech vaccine reduces the risk of hospitalisation by 93% from the B.1.1.7 (Kent) variant.

PHE analysis also shows that individuals who receive a single dose of the Oxford/AstraZeneca vaccine have approximately 80% lower risk of death against the B.1.1.7 coronavirus variant originating in Kent and a second dose of the vaccine can provide 85-90% protection against symptomatic disease. Protection against death from the Pfizer-BioNTech vaccine rises from approximately 80% after one dose to 97% after 2 doses against the Kent variant.

A new study by PHE shows that 2 doses of the COVID-19 vaccines are highly effective against the B.1.617.2 variant first identified in India. Vaccine effectiveness against symptomatic disease from the B.1.617.2 variant is similar after 2 doses compared to the B.1.1.7 (Kent) variant dominant in the UK, and we expect to see even higher levels of effectiveness against hospitalisation and death.

Data published by YouGov shows the UK continues to top the list of nations where people are willing to have a COVID-19 vaccine or have already been vaccinated.

ONS data published on 6 May found that more than 9 in 10 (93%) adults reported positive sentiment towards the vaccine.

Approved vaccines are available from thousands of NHS vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England and vaccinations are taking place at sites including mosques, community centres and football stadiums.

The latest UK-wide vaccination statistics are published here 

Vaccines are ‘highly effective’ against Indian variant

New study shows that 2 doses of the COVID-19 vaccines are highly effective against the B.1.617.2 variant first identified in India

Vaccine effectiveness against symptomatic disease from the B.1.617.2 variant is similar after 2 doses compared to the B.1.1.7 (Kent) variant dominant in the UK, and Public Health England expect to see even higher levels of effectiveness against hospitalisation and death.

The study found that, for the period from 5 April to 16 May:

  • the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the B.1.617.2 variant 2 weeks after the second dose, compared to 93% effectiveness against the B.1.1.7 variant
  • 2 doses of the AstraZeneca vaccine were 60% effective against symptomatic disease from the B.1.617.2 variant compared to 66% effectiveness against the B.1.1.7 variant
  • both vaccines were 33% effective against symptomatic disease from B.1.617.2, 3 weeks after the first dose compared to around 50% effectiveness against the B.1.1.7 variant

The analysis included data for all age groups from 5 April to cover the period since the B.1.617.2 variant emerged. It included 1,054 people confirmed as having the B.1.617.2 variant through genomic sequencing, including participants of several ethnicities. Data published on Thursday 20 May for vaccine effectiveness covered the period since December for those aged over 65.

The difference in effectiveness between the vaccines after 2 doses may be explained by the fact that rollout of second doses of AstraZeneca was later than for the Pfizer-BioNTech vaccine, and other data on antibody profiles show it takes longer to reach maximum effectiveness with the AstraZeneca vaccine.

As with other variants, even higher levels of effectiveness are expected against hospitalisation and death. There are currently insufficient cases and follow-up periods to estimate vaccine effectiveness against severe outcomes from the B.1.617.2 variant. PHE will continue to evaluate this over the coming weeks.

Health and Social Care Secretary Matt Hancock said: This new evidence is groundbreaking – and proves just how valuable our COVID-19 vaccination programme is in protecting the people we love.

“We can now be confident that over 20 million people – more than 1 in 3 – have significant protection against this new variant, and that number is growing by the hundreds of thousands every single day as more and more people get that vital second dose. I want to thank the scientists and clinicians who have been working around the clock to produce this research.

“It’s clear how important the second dose is to secure the strongest possible protection against COVID-19 and its variants – and I urge everyone to book in their jab when offered.”

Dr Mary Ramsay, Head of Immunisation at PHE, said: “This study provides reassurance that 2 doses of either vaccine offer high levels of protection against symptomatic disease from the B.1.617.2 variant.

“We expect the vaccines to be even more effective at preventing hospitalisation and death, so it is vital to get both doses to gain maximum protection against all existing and emerging variants.”

Minister for COVID-19 Vaccine Deployment Nadhim Zahawi said: Almost every day we get more and more encouraging evidence about the difference our COVID-19 vaccines are making to people’s lives – with 13,000 lives saved and 39,100 hospitalisations prevented overall.

“Today’s data is astounding and a true reflection of just how important it is to get both your jabs when offered.

“I encourage all those offered an appointment to get their jab booked in as soon as possible and take full advantage of the high levels of protection the vaccines bring.”

Launch of Lowland Hall Mass Vaccination Centre at Ingliston

This week NHS Lothian launched their biggest COVID-19 vaccination centre so far in a bid to deliver more lifesaving vaccinations. The first of thousands of patients have begun streaming through the Lowland Hall at the Royal Highland Centre, Ingliston.

Vaccination teams opened the doors to the huge centre which has 50 vaccination stations with the potential to increase, if required.By opening Lowland Hall, we will be able to more than triple our current capacity.

We will deliver 18,000 vaccines every day as the numbers of patients eligible for the jab increases in line with the population mix in Lothian.

We look forward to welcoming you to the Lowland Hall.

Protecting Scotland against COVID

Appeal for those who missed vaccine appointments to come forward  

Anyone who was part of vaccine priority groups 1-9 and missed their original appointment is being asked to come forward to arrange their vaccination.

This includes everyone 50 or over, adults on the shielding list, anyone with underlying health conditions, and unpaid carers.

Invitations have been issued to everyone aged 40 or over, with 30-39-year olds starting to be invited now. In the specific areas of Glasgow affected by the current outbreak, all 18-39 year olds are being invited with older age groups first.

Anyone who believes they should have had a letter by now with details of either their first or second dose should call the national helpline or fill out the missing appointments form on the NHS Inform site.

The system for handling missed appointments has recently been streamlined in order to speed up the process.

More than three million people – two thirds of the adult population – have now received their first dose. However, in response to the new variant currently circulating in parts of the UK, and in line with updated JCVI advice, second doses which are not already scheduled, are being brought forward from 12 weeks to eight weeks across Scotland where supply allows.

Chief Medical Officer Dr Gregor Smith said: “Our vaccination programme has been extremely successful, and we’ve seen very high uptake rates across all age groups. However, we know that there will inevitably be a small number of people who, for a variety of reasons, may not have taken up their original appointment.

Our message to you is clear – it is not too late, and you are still welcome. Please contact us to make an appointment today.

“It continues to be vitally important that everyone takes up the opportunity to get both doses of their vaccination when their opportunity arrives. I want to emphasise that the second dose offers greater and longer lasting protection, and should not be missed.

“Vaccination is crucial in protecting ourselves, our families and communities and helping us on the path back to normality.

“Anyone who missed their original appointment, or thinks they may have been missed, should contact the Vaccination Helpline on 0800 013 8013 or fill out the missing appointment form on the NHS Inform website. They can also help you find other ways to get your coronavirus vaccination if you are unable to leave your home for your appointment on medical grounds.

“People who have been vaccinated should still continue to get tested and engage with contact tracing teams if they are a contact of a positive case. While the latest evidence suggests vaccines provide a high level of protection, they don’t yet provide a guarantee that you can’t still get the virus or pass it on to others around you.”

Vaccine boost for the high street as consumer spending increases – but many big cities lag behind

Vaccine boost for the high street as consumer spending increases across the country – but many big cities continue to lag behind

  • Consumer spending highest in North and Midlands after restrictions eased last month
  • But shops, restaurants and pubs in London and other big cities continue to struggle
  • Government and newly elected metro mayors need a plan to bring visitors back to city centres

April’s lifting of lockdown restrictions provided a much-needed boost to many high streets as spending surged to pre-pandemic levels in more than half of Britain’s cities and large towns – but cities are continuing to struggle.

New data from Centre for Cities’ High Street Recovery Tracker suggests that spending in Britain’s large towns and smaller cities are recovering faster than in its largest urban centres. Northern England and the Midlands is also so far recovering faster than elsewhere – of the 35 places studied where spending has returned to pre-pandemic levels, 20 are in the North and Midlands.

So far, high street spending has recovered the most in Huddersfield, Basildon and Blackburn, while London, Aldershot, Oxford and Birmongham have seen the weakest recoveries in England so far.

Although spending in Scottish cities is the lowest in the UK in April, retail and hospitality opened on a later date than in England.

Cities where spending levels are highest
RankCityApril 2021 spending (% of pre-lockdown)Difference to week before reopening (percentage points)Difference to summer 2020 reopening (percentage points)
1Huddersfield119%4819
2Basildon117%6532
3Blackburn117%5417
4Birkenhead117%8012
5Mansfield117%7729
Cities where spending levels are lowest
RankCityApril 2021 spending (% of pre-lockdown levels)Difference to week before reopening (percentage points)Difference to summer 2020 reopening (percentage points)
54Newcastle72%6132
55Birmingham65%5628
56Oxford62%4529
57Aldershot56%152
58London53%3426
59Dundee34%-1-4
60Aberdeen24%-10
61Glasgow18%2-12
62Edinburgh12%24

While high street spending in many larger cities remains below pre-lockdown levels, it is now significantly higher than it was this time last year – suggesting that consumer confidence is returning as more and more people are vaccinated and the pandemic ends.

Despite these positive signs, the Government and England’s newly elected metro mayors must set out plans to encourage people to return to the centres of our largest cities. Without the return of visitors, tourists and office workers thousands of jobs in shops, restaurants, pubs and other city centre services remain under threat.

Centre for Cities’ Chief Executive Andrew Carter said: “We can already see that the vaccination programme and lifting of lockdown is helping businesses get back on their feet. Many cities and towns, particularly those in Northern England and the Midlands, have seen a boom in consumer spending in the past month.

“It’s not all good news, the centres of our biggest cities such as London, Birmingham and Manchester remain quiet as people there continue to work from home. If this doesn’t change in the next few months I’d expect to see more people working in retail and hospitality in our biggest city centres lose their jobs. The Government must work with the newly-elected metro mayors to stop this happening.”

UK secures extra 60 million Pfizer/BioNTech vaccines

  • The government’s Vaccines Taskforce has purchased an additional 60 million doses of the Pfizer/BioNTech vaccine
  • Move will ensure people have the strongest possible protection from COVID-19

An extra 60 million doses of the Pfizer/BioNTech vaccine have been secured by the UK government to help support the booster COVID-19 vaccination programme beginning from the Autumn.

To protect the most vulnerable ahead of the winter, the government is preparing for a booster programme based on clinical need to ensure people have the strongest possible protection against COVID-19.

The additional Pfizer/BioNTech jabs will be used alongside other approved COVID-19 vaccines for the booster programme.

This comes as new data from Public Health England shows that one dose of a COVID-19 vaccine reduces household transmission of the virus by up to half.

Health and Social Care Secretary Matt Hancock said: “Our vaccination programme is bringing back our freedom, but the biggest risk to that progress is the risk posed by a new variant.

“We’re working on our plans for booster shots, which are the best way to keep us safe and free while we get this disease under control across the whole world.

“These further 60 million doses will be used, alongside others, as part of our booster programme from later this year, so we can protect the progress that we’ve all made.”

The government will publish further details on the booster programme in due course and the final policy will be informed by advice from the Joint Committee on Vaccination and Immunisation (JCVI) and the results of clinical trials studying the use of different combinations of approved COVID-19 vaccines.

Vaccines Minister Nadhim Zahawi said: “We are doing everything we can to make sure the most vulnerable are protected from COVID-19 now and in the future.

“Our brilliant Vaccines Taskforce has secured an extra 60 million doses of the Pfizer/BioNTech vaccines to support our booster programme, which will be developed in line with the advice of our experts.

“In the meantime, we are making great progress with our vaccination rollout and I urge everybody to get their vaccines as soon as they are eligible.”

Overall, the UK has secured access to 517 million doses of eight of the most promising COVID-19 vaccines. These are:

  • Pfizer/BioNTech for 100 million doses – including the additional 60 million doses
  • Oxford/AstraZeneca for 100 million doses
  • Moderna for 17 million doses
  • Janssen for 30 million doses
  • Novavax for 60 million doses
  • Valneva for 100 million doses
  • GlaxoSmithKline and Sanofi Pasteur for 60 million doses
  • CureVac for 50 million doses

Health services across the UK have now administered a total of 47,540,984 million vaccines between 8 December and 27 April, including 33,959,908 million people with their first dose (64.5% of all adults) and 13,581,076 million with their second (25.8% of all adults).

All vaccines being used in the UK have met the independent Medicines and Healthcare products Regulatory Agency’s (MHRA) strict standards of safety, effectiveness and quality.

Rolling reviews are underway by the MHRA to assess the Janssen and Novavax vaccines. Clinical trials are ongoing for the Valneva, GSK and Sanofi and CureVac jabs.

The UK government has already hit its target of offering everybody in cohorts 1 to 9 – those aged 50 and over, the clinically vulnerable and health and social care workers – a first dose of the vaccine by 15 April and remains on track to offer a jab to all adults by the end of July.

Data from the ONS and Oxford University shows that COVID-19 infections fell significantly by 65% after the first dose of the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, rising further after the second dose.

Data from Public Health England’s real-world study shows the vaccines are already having a significant impact in the UK, reducing hospitalisations and deaths, saving more than 10,000 lives between December and March.

A recent survey published by ONS showed that 92% of those who had been vaccinated with a first dose did not experience any difficulties when going to get their vaccine – such as difficulty travelling to the vaccination site, concerns over catching the virus while there or having a long wait for their appointment.

Vaccines are available from thousands of NHS vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England and vaccinations are taking place at sites including mosques, community centres and football stadiums.

Ben Osborn, Country Manager at Pfizer UK, said: “By more than doubling our supply commitment to the UK, we are delighted to support the ongoing rollout of the UK immunisation programme and help the government in its efforts to address the pandemic.

“Along with our partner BioNTech, we are working relentlessly to support vaccination campaigns worldwide and, based on current projections, believe we can deliver more than 2.5 billion doses of our vaccine globally by the end of 2021.”

The latest UK-wide vaccination statistics are published here

Photographs show the people behind the ‘national’ vaccination effort – but no pics from Scotland

The UK Government has published a series of photographs taken by photojournalists working with the NHS, showcasing the people behind the ‘UK-wide vaccination programme’ – but none of them are from Scotland.

  • Working with the NHS, photojournalists have captured the monumental collective effort of the largest vaccination programme in British history in a series of poignant, never-before-seen photographs
  • Images show intimate moments across the UK, including in Salisbury Cathedral, the Royal Welsh Showground in mid-Wales and on Rathlin Island in Northern Ireland
  • The new photo montage comes as over 45.5 million jabs in total have been administered across the UK in over 2,800 vaccination sites

From care homes to cathedrals and museums to stadiums, photojournalists Jude Palmer, Glenn Edward and Liam McBurney toured the UK over the past few months capturing intimate moments during the monumental national effort to vaccinate the British population and end the (coronavirus) COVID-19 pandemic.

A series of unseen photographs capturing the size and scale of the UK-wide vaccination programme have been published by the UK government ahead of a new campaign urging under-50s to get the jab.

Health and Social Care Secretary Matt Hancock said: “These incredible photographs show the heroic efforts of thousands of vaccinators and volunteers in every corner of the UK who have given so much to protect the most vulnerable in our society against this cruel virus.

“While there is much to celebrate with over 45 million COVID-19 vaccine doses administered so far, the battle is not yet over. I urge everyone to do their bit – when you get the call, get the jab.”

Photographs include smiling portraits of vaccinators and volunteers, a bird’s eye view of socially distanced patients awaiting their jabs in Salisbury Cathedral, and an elderly couple holding hands at a vaccination site in Ulverston, Cumbria.

Jude Palmer, photojournalist, said: “While the pandemic has been an incredibly difficult time in our history, it had to be documented. It’s been an honour to witness the incredible roll out of the life-saving vaccine first-hand and document this in a meaningful, compassionate way.

“The photography project tells many genuine stories of people involved in the vaccine programme and those that have come forward to have their vaccine already – from their smiles, laughs, nerves, and sighs of relief as we get one step closer to a more normal way of life.”

The UK Government has already hit its target of offering everybody in cohorts 1 to 9 – those aged 50 and over, the clinically vulnerable and health and social care workers – and is on track to offer a jab to all adults in the UK by the end of July.

Over 33.5 million people have now received a first dose of a vaccine – over 63.5% of the UK adult population – with 12 million receiving their second dose. This means over 22.8% of the UK adult population have now received both doses of a vaccine – giving them the strongest possible protection from this virus, with over 45.5 million vaccines administered overall.

Throughout February and March, Palmer, Edward and McBurney visited the Science Museum in London, Salisbury Cathedral, the Royal Welsh Showground in mid-Wales (above) and Rathlin Island in Northern Ireland, as well as hospitals, mobile vaccination units, care homes and pop-up vaccination sites.

These never-before-seen images, which illustrate the monumental and collective effort of NHS teams, volunteers and members of the public, have been compiled into a video montage to mark the success of the vaccine programme to date.

They provide an opportunity for people to look back on the programme, reflecting on the heroic efforts to protect those most vulnerable to COVID-19 and look ahead to the second phase of the vaccination programme, which will see all adults offered a first dose by the end of July.

A major new campaign marking the second phase of the national vaccination rollout will be launched today to encourage people aged 50 and under to get their jab when their turn comes.

Alice Tooley, 25, a Volunteer Service Co-Ordinator at refugee charity RETAS in Leeds, who is featured in the photography (above) said: “I was invited to get the vaccine because of my frontline work with vulnerable adults.

“Getting the vaccine was important to me as it meant I could continue my work with asylum seekers and refugees feeling confidence that I wasn’t putting them or myself at risk of the virus.

“As younger people my age get called for theirs, I hope they jump at it the way I did so, as a collective, we all play our part in getting back to a more normal way of life.”

Dr Gavin Chestnutt, 42, GP Partner at Ballycastle Medical Practice and part-time farmer, is seen vaccinating a 92 year-old man in his front garden overlooking the Rathlin Island coastline, Northern Ireland (above).

He said: “It’s been a real honour to play such a central part in the vaccine roll out programme and witness people’s physical relief as they get their first and second jabs. To save elderly people travelling to the clinic through snow and frosty conditions, I’ve been travelling round on boats and by car to reach the most remote corners of Northern Ireland.”

“Most overwhelming has been to see how grateful everyone has been for getting their vaccine and finally seeing some light at the end of the tunnel.”

Just to compensate for the lack of Scottish content, here are a just a few from Greater Glasgow and Clyde! – Ed.

Ten million people in UK receive second dose of COVID-19 vaccine

  • More than 10 million people in the UK vaccinated with a second dose of a COVID-19 jag
  • Almost one in five adults in the UK have now received both doses
  • People urged to take up their second doses to maximise protection

Over 10 million people in the UK have received their second dose of a COVID-19 vaccine.

Health services across the UK have now administered a total of 43,084,487 million vaccines between 8 December and 18 April, including 32,932,448 million people with their first dose and 10,152,039 million with their second.

The milestone means over 19% of all UK adults have received both vaccines.

Prime Minister Boris Johnson said: “Vaccines offer us the best possible protection from the virus, so it is fantastic that 10 million people have now received their second dose.

This is another remarkable milestone in our vaccination programme, which has already saved thousands of lives.

“I want to thank the brilliant staff and volunteers involved in the rollout, and urge all those who are called to keep coming forward.”

Health and Social Care Secretary Matt Hancock said: “This is another terrific milestone, meaning over ten million people who are the most vulnerable to COVID in the UK now have double protection from this awful virus.

“Second doses are crucial to maximising the strength and duration of your protection from COVID-19 and I’m urging everybody eligible to get their jab as soon as possible.

“This milestone is thanks to the dedication and tireless efforts of our NHS workers, volunteers, civil servants and everybody working on the frontline to save lives and stop this virus in its tracks.”

The government has already hit its target of offering everybody in cohorts 1 to 9 – those aged 50 and over, the clinically vulnerable and health and social care workers – a first dose of the vaccine by 15 April and remains on track to offer a jab to all adults by the end of July.

Vaccine Minister Nadhim Zahawi said: “Vaccines have already saved more than 10,000 lives and they are the best way to protect you and your loved ones from this dreadful disease.

“We want to send this virus into retreat. No matter who you are, where you live, your race or your religion, I encourage everyone to get both doses when offered and help this country return life to normal.”

All vaccines being used in the UK have undergone robust clinical trials and have met the independent Medicines and Healthcare products Regulatory Agency’s strict standards of safety, effectiveness and quality. Rolling reviews are underway by the MHRA to assess the Janssen and Novavax vaccines.

The speed and breadth of the UK vaccination programme means even more people will soon develop strong protection from serious illness from COVID-19 infection, saving countless lives and significantly reducing pressure on the NHS.

Data from Public Health England’s real-world study shows the vaccines are already having a significant impact in the UK, reducing hospitalisations and deaths, saving more than 10,000 lives between December and March.

Approved vaccines are available from thousands of NHS vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England and vaccinations are taking place at sites including mosques, community centres and football stadiums.

The latest UK-wide vaccination statistics are published here.

PHE’s real-world data on the efficacy of Covid-19 vaccines is available here.

Through the government’s Vaccines Taskforce, the UK has secured early access to 457 million doses of eight of the most promising vaccine candidates, including:

  • BioNTech/Pfizer for 40 million doses
  • Oxford/AstraZeneca for 100 million doses
  • Moderna for 17 million doses
  • Janssen for 30 million doses
  • Novavax for 60 million doses
  • Valneva for 100 million doses
  • GlaxoSmithKline and Sanofi Pasteur for 60 million doses
  • CureVac for 50 million doses

To date, the government has invested over £300 million into manufacturing a successful vaccine to enable a rapid roll out.

The UK government is committed to supporting equitable access to vaccines worldwide. The UK is the largest donor to the COVAX facility, the global mechanism to help developing countries access a coronavirus vaccine, and has committed £548 million in UK aid to help distribute 1.3 billion doses of coronavirus vaccines to 92 developing countries this year.

‘Vaccine Inclusion: reducing inequalities one vaccine at a time’

Voluntary Health Scotland launches new report

Voluntary Health Scotland (VHS) has launched its briefing report ‘Vaccine Inclusion – Reducing inequalities one Vaccine at a time.

The report explores the key barriers and enablers to accessing the COVID-19 vaccine and how the vaccine delivery model can be improved to reduce inequalities and provide holistic support to those who need it the most.

The key messages from the report are that our health system has a clear moral and human rights duty to those vulnerable groups who fall through the gaps of public service provision to ensure that they are not failed by this crucially important public health intervention.

Some of the key demographics highlighted within the research are at very high risk if they do contract COVID-19, including people who are homeless, prisoners, people living in poverty, people who abuse drugs and alcohol, black and ethnic minority groups, gypsy travellers, refugees and asylum seekers.

The report calls against viewing the Covid-19 vaccine programme as a silo: the programme has to be part of a whole-system, preventative approach to public health and to health inequalities. This requires a joined up suite of interventions that not only help people access the vaccine but supports them to stay well afterwards and enables them to adhere to the Covid-19 regulations safely.

There are a number of recommendations calling for improvements in the communications relating to the COVID-19 vaccine, a need to prioritise collection and analysis of local data about uptake of Covid-19 vaccine by different communities and groups as well as the need to conduct active research into the ongoing vaccination programme.

The report also recommends developing a rolling programme of outreach vaccination clinics, services and events as well as provision of accessible, affordable transport to vaccine centres and clinics.

Finally, the report highlights the importance of involving third sector and community partners in the planning, communications and delivery of public health interventions that could help prevent, mitigate and reduce health inequalities.

The findings of the report will be shared with Scottish Government, Public Health Scotland, NHS Boards as well as a range of key stakeholders across the third sector.